RUTHIGEN
They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based (HOCl) therapeutics designed to prevent and treat infection in invasive applications.
RUTHIGEN
Social Links:
Industry:
Biotechnology Health Care
Founded:
2013-01-01
Address:
Santa Rosa, California, United States
Country:
United States
Website Url:
http://www.ruthigen.com
Total Employee:
11+
Status:
Active
Contact:
707-525-9900
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx
Similar Organizations
Stock Details
Official Site Inspections
http://www.ruthigen.com
- Host name: 162.255.119.159
- IP address: 162.255.119.159
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Ruthigen"
Ruthigen - Crunchbase Company Profile & Funding
They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based (HOCl) therapeutics …See details»
Ruthigen Company Profile 2024: Valuation, Investors, Acquisition ...
Ruthigen is headquartered in Santa Rosa, CA. What is the size of Ruthigen? Ruthigen has 10 total employees. What industry is Ruthigen in? Ruthigen’s primary industry is Drug Delivery. Is …See details»
Ruthigen - Products, Competitors, Financials, Employees, …
Ruthigen is a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous acid-based (HOCl) therapeutics …See details»
Ruthigen Company Profile | Management and Employees List
Ruthigen is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive …See details»
Ruthigen - Overview, News & Similar companies | ZoomInfo.com
Ruthigen is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and t reat infection in invasive …See details»
Press Releases - Pulmatrix
Mar 16, 2015 · Santa Rosa, Ca., March --- March 16, 2015 – Ruthigen, Inc. (NASDAQ: RTGN) (“Ruthigen”), and Pulmatrix, Inc., (“Pulmatrix”), a Lexington, Massachusetts based clinical …See details»
Ruthigen - Funding, Financials, Valuation & Investors - Crunchbase
Ruthigen is registered under the ticker NASDAQ:RTGN . Their stock opened with $7.25 in its Mar 21, 2014 IPO.See details»
Ruthigen - Crunchbase
They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorousSee details»
Santa Rosa’s Ruthigen merges with Massachusetts startup
Mar 16, 2015 · Santa Rosa-based biotech company Ruthigen is merging with Massachusetts-based Pulmatrix, Inc., a startup that is developing a new type of inhaled drug delivery method. …See details»
Ruthigen Establishes Independent Headquarters and Targets …
Ruthigen, Inc. is a fully owned subsidiary of Oculus Innovative Sciences, Inc. (Nasdaq:OCLS). Ruthigen focuses on the development of RUT58-60, a drug candidate intended for …See details»
Ruthigen and Pulmatrix Stockholders Approve Merger - PR …
Jun 12, 2015 · Ruthigen is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive …See details»
Ruthigen and Pulmatrix Enter into Merger Agreement - PR Newswire
Mar 16, 2015 · Upon completion of the merger, Ruthigen will be renamed Pulmatrix, and, pending NASDAQ approval of the merger, the surviving company's common stock will continue to …See details»
Pulmatrix acquires Ruthigen - 2015-03-16 - Crunchbase
Acquiring Organization: Pulmatrix Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases. Announced …See details»
Ruthigen Cleared to Initiate Human Clinical Trials for ... - PR …
Jun 12, 2014 · /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics...See details»
Ruthigen: More Potential Than Appears Due To New Partners
Apr 21, 2015 · Ruthigen is working on a transformative merger with Pulmatrix to raise the quality and value of the company. The new company will have a strong drug pipeline including a drug …See details»
Ruthigen and Pulmatrix to merge (NASDAQ:PULM) - Seeking Alpha
Thinly-traded nano cap Ruthigen (OTC:RTGN) is up 12% premarket, albeit on only 2,200 shares, in response to its announcement of its merger with...See details»
Ruthigen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorousSee details»
Ruthigen Announces the Distribution of Letter to Stockholders
Jun 4, 2014 · Ruthigen, whose fiscal year end is March 31, is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed …See details»
Ruthigen IPO Set To Soar; Tetraphase To Find Lower Floor
Mar 25, 2014 · Ruthigen's IPO provides strong investment opportunity based on relative valuations and addressing unmet market need with potential multi-billion dollar...See details»
Ruthigen Poised To Hit It Out Of The Park
Jun 26, 2014 · Ruthigen is developing a low-tech, common sense solution to meet a significant medical need. The indication allows the company to move quickly, with IND to NDA taking only …See details»